Ηλίας Δράκος

3.1k citations
71 papers · 2.1k indexed · h-index 28
Topics
Lymphoma Diagnosis and Treatment (29 papers)Cancer-related Molecular Pathways (11 papers)PI3K/AKT/mTOR signaling in cancer (5 papers)

In The Last Decade

Ηλίας Δράκος

70 papers receiving 2.1k citations

Peers

Ηλίας Δράκος
Comparison fields: 5 of 107
  • Molecular Biology 1.1k
  • Oncology 648
  • Pathology and Forensic Medicine 457
  • Immunology 420
  • Cancer Research 314
Replace Michał Marzec with:
Michał Marzec United States
Masaaki Higashihara Japan
Tsuyoshi Takami Japan
Yan Shi China
James P. Grenert United States
Takeshi Hara Japan
Atsushi Kaneda Japan
Federico Perosa Italy
Michael Bonelli Austria
Kyeong Cheon Jung South Korea
Ηλίας Δράκος relative to Michał Marzec United States Michał Marzec's profile →
Citations per field
00.5×1.5×1.9×
Michał Marzec · 1×
Citations per year

Countries citing papers authored by Ηλίας Δράκος

Since Specialization
Citations

This map shows the geographic impact of Ηλίας Δράκος's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ηλίας Δράκος with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ηλίας Δράκος more than expected).

Fields of papers citing papers by Ηλίας Δράκος

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ηλίας Δράκος. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ηλίας Δράκος. The network helps show where Ηλίας Δράκος may publish in the future.

Co-authorship network of co-authors of Ηλίας Δράκος

This figure shows the co-authorship network connecting the top 25 collaborators of Ηλίας Δράκος. A scholar is included among the top collaborators of Ηλίας Δράκος based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ηλίας Δράκος. Ηλίας Δράκος is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 7
4 5
5 35
6 26
7 3
8 9
9 1
10 50
11 7
12 24
13 12
14 63
15 74
16 14
17 37
18 33
19 6
20 30

About Ηλίας Δράκος

Ηλίας Δράκος is a scholar working on Pathology and Forensic Medicine, Oncology and Cancer Research, having authored 71 papers that have together received 2.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (29 papers), Cancer-related Molecular Pathways (11 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (457 citations), Oncology (648 citations) and Cancer Research (314 citations). Ηλίας Δράκος has collaborated with scholars based in Greece, United States and Sweden. Frequent co-authors include L. Jeffrey Medeiros, George Z. Rassidakis, Vasiliki Leventaki, Konstantina Georgila, Francisco Vega, Dimitrios T. Boumpas, Ellen Schlette, Jeong Hee Cho‐Vega, François X. Claret and Evangelia Peponi. Their work appears in journals such as Blood, The Journal of Immunology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026